BCG secreting IFN-α-2b induced higher levels of IFN-γ, TNF-α, IL-12, and lymphoproliferation as well as increased antiproliferative and cytotoxic effect on bladder cancer cells in vitro [72]. The gene discussed is IFNA2; the disease is urinary bladder cancer.